Page last updated: 2024-08-23

cefonicid and aztreonam

cefonicid has been researched along with aztreonam in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C1
Bosso, JA; Marble, DA; Townsend, RJ1
Harvengt, C1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1

Other Studies

4 other study(ies) available for cefonicid and aztreonam

ArticleYear
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
    Diagnostic microbiology and infectious disease, 1987, Volume: 7, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; Cefamandole; Cefonicid; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Enterococcus faecalis; Escherichia coli; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quality Control; Thienamycins

1987
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
    Drug intelligence & clinical pharmacy, 1988, Volume: 22, Issue:1

    Topics: Aztreonam; Cefamandole; Cefonicid; Cefoperazone; Cefuroxime; Cephalosporins; Clindamycin; Drug Combinations; Drug Incompatibility; Drug Packaging; Drug Stability; Syringes

1988
Drugs recently released in Belgium: aztreonam, cefotetan, cefonicid.
    Acta clinica Belgica, 1986, Volume: 41, Issue:3

    Topics: Aztreonam; Cefamandole; Cefonicid; Cefotetan; Cephamycins; Humans

1986
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004